JOHN LEICHNER: Open Payments
NPI 1225072192 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$158 in 8 payments from 5 companies in 2025. Trend: 2023 $195 · 2024 $96 · 2025 $158
Food & beverage: $158
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $65 |
| ABBVIE INC. | 2 | $31 |
| Luye Pharma (USA) Ltd. | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
Products named: LINZESS, ERZOFRI EXTENDED-RELEASE, Wegovy, Rybelsus, Ozempic, XIFAXAN, Cologuard Collection Kit.
Industry payments across PA — which companies pay providers there.
